Your Source for Venture Capital and Private Equity Financings

Waypoint Bio Launches with $14.5M Seed Funding

2024-06-28
NEW YORK, NY, Waypoint Bio, a biotechnology company pioneering novel cell therapies, announced $14.5 million in seed funding led by Hummingbird Ventures.
Waypoint Bio, a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology, announced $14.5 million in seed funding led by Hummingbird Ventures with participation from other institutional investors, including Recode Ventures and pre-seed lead Fifty Years.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors